Misplaced Pages

Etiracetam: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 21:12, 23 July 2007 editCcroberts (talk | contribs)Extended confirmed users662 edits 3d structure← Previous edit Revision as of 06:37, 26 August 2007 edit undoMysid (talk | contribs)Extended confirmed users13,497 edits →svgNext edit →
Line 1: Line 1:
{{Drugbox| {{Drugbox|
|IUPAC_name = ''2-(2-oxopyrrolidin-1-yl)butanamide'' |IUPAC_name = ''2-(2-oxopyrrolidin-1-yl)butanamide''
| image = Etiracetam.png | image = Etiracetam structure.svg
| width = 106 | width = 106
| image2= Etiracetam3d.png | image2= Etiracetam3d.png

Revision as of 06:37, 26 August 2007

Pharmaceutical compound
Etiracetam
Clinical data
Routes of
administration		Oral
Legal status
Legal status
  • Unscheduled (US)
Identifiers
IUPAC name
  • 2-(2-oxopyrrolidin-1-yl)butanamide
PubChem CID
CompTox Dashboard (EPA)
ECHA InfoCard100.111.445 Edit this at Wikidata
Chemical and physical data
FormulaC8H14N2O2
Molar mass170.209 g/mol g·mol
3D model (JSmol)
SMILES
  • CCC(C(=O)N)N1CCCC1=O

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active optical form is levetiracetam.

See also

Racetams
Racetams
Phenylpiracetams
Racetam-like


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
Etiracetam: Difference between revisions Add topic